MedTrace Logo

Hepassocin Levels in Patients With Polycystic Ovary Syndrome

NCT04369248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-04-30

No results posted yet for this study

Summary

The investigators aimed to investigate hepassocin levels in patients with polycystic ovary syndrome (PCOS). There are 3 groups aged between 18 and 35 years as non-obese healthy women, non-obese women with PCOS, and obese women (BMI\>30) with PCOS.

Conditions

Interventions

OTHER

hepassocin

hepassocin levels in polycystic ovary syndrome

Sponsors & Collaborators

  • Fatma ketenci gencer

    lead OTHER_GOV

Principal Investigators

  • fatma ketenci gencer · Gaziosmanpasa Taksim Education and Research Hospital

  • sibel bektas · Gaziosmanpasa Taksim Education and Research Hospital

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-03
Primary Completion
2020-03-15
Completion
2020-03-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04369248 on ClinicalTrials.gov